41-50 items (total 704)
Published on May 01, 2025
New Hope for Treating Small-Cell Lung Cancer, a Major Intractable Cancer—Potential Efficacy of IGF1R Inhibitors for Non-Neuroendocrine Subtype
Office of Communications and Public Relations
Published on December 26, 2024
Students Submit Final Proposals to the University President for the 2024 Keio Student Conference
Office of Communications and Public Relations
Published on December 26, 2024
Successful Elucidation of the Involvement of Gut Microbiota and Their Short-Chain Fatty Acids in Chronic Obstructive Pulmonary Disease (COPD)—Anticipating New Therapeutic Strategies Focused on Dietary Fiber—
Office of Communications and Public Relations
Published on December 26, 2024
KEIO TECHNO-MALL 2024 (The 25th KEIO TECHNO-MALL) Held
Faculty of Science and Technology/Graduate School of Science and Technology
Published on December 25, 2024
Keio University and Sumitomo Mitsui Banking Corporation Sign Agreement on Industry-Academia Collaboration and Support for Startup Creation
Office of Communications and Public Relations
Updated on December 26, 2024
Seven Researchers from Keio University Selected among the World's Most Influential Researchers (Highly Cited Researchers 2024)
Office of Communications and Public Relations
Published on December 20, 2024
Development of a Method for Inducing Motor Neurons from Human iPS Cells and a Single-Cell Evaluation Method—Toward Elucidating the Pathophysiology of Sporadic ALS and Developing New Therapies
Office of Communications and Public Relations
Published on December 16, 2024
Elucidating the Mechanism by Which Social Isolation Promotes Atherosclerosis—New Findings on the Health Benefits of Oxytocin Generated Through “Bonds”—
Office of Communications and Public Relations
Published on December 16, 2024
Heart Failure with Preserved Ejection Fraction Ameliorated by Cardiac Direct Reprogramming—Successful Development of a Novel Gene Therapy Targeting Cardiac Fibrosis in Heart Failure—
Office of Communications and Public Relations
Published on December 13, 2024
Utilizing Commercially Available Reagents: Development of a Simple Method for Conjugating Functional Molecules to the N-Terminus of Proteins—Expected Applications in the Development of Biopharmaceuticals and Biomaterials—
Office of Communications and Public Relations